Guixi Zheng

2.2k total citations
55 papers, 1.7k citations indexed

About

Guixi Zheng is a scholar working on Molecular Biology, Cancer Research and Immunology. According to data from OpenAlex, Guixi Zheng has authored 55 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Molecular Biology, 28 papers in Cancer Research and 10 papers in Immunology. Recurrent topics in Guixi Zheng's work include Cancer-related molecular mechanisms research (22 papers), MicroRNA in disease regulation (19 papers) and Circular RNAs in diseases (12 papers). Guixi Zheng is often cited by papers focused on Cancer-related molecular mechanisms research (22 papers), MicroRNA in disease regulation (19 papers) and Circular RNAs in diseases (12 papers). Guixi Zheng collaborates with scholars based in China, United States and Canada. Guixi Zheng's co-authors include Chuanxin Wang, Lutao Du, Yongmei Yang, Ailin Qu, Zhaogang Dong, Lili Wang, Lili Wang, Xin Zhang, Xin Zhang and Xin Zhang and has published in prestigious journals such as PLoS ONE, Cancer Research and Scientific Reports.

In The Last Decade

Guixi Zheng

50 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Guixi Zheng China 24 1.2k 1.2k 254 188 168 55 1.7k
Chang–Gong Liu United States 11 2.0k 1.7× 1.9k 1.6× 273 1.1× 149 0.8× 103 0.6× 13 2.5k
Qiong Shao China 17 1.3k 1.0× 1.1k 0.9× 446 1.8× 110 0.6× 219 1.3× 41 1.8k
Xianjuan Shen China 25 1.1k 0.9× 1.1k 0.9× 261 1.0× 110 0.6× 124 0.7× 64 1.5k
Natalia Ramírez Spain 14 1.3k 1.1× 1.3k 1.1× 230 0.9× 61 0.3× 62 0.4× 32 1.7k
Fulin Qiang China 23 814 0.7× 556 0.5× 349 1.4× 104 0.6× 126 0.8× 37 1.3k
Jianbin Xiang China 22 770 0.6× 641 0.5× 438 1.7× 235 1.3× 224 1.3× 75 1.4k
Yong Song China 14 2.0k 1.6× 2.0k 1.7× 167 0.7× 105 0.6× 121 0.7× 18 2.3k
Guoen Fang China 16 945 0.8× 856 0.7× 278 1.1× 193 1.0× 131 0.8× 33 1.5k
Piet J. Pretorius South Africa 13 588 0.5× 710 0.6× 232 0.9× 60 0.3× 172 1.0× 22 1.0k
Nadia Felli Italy 19 2.3k 1.9× 1.9k 1.6× 208 0.8× 64 0.3× 103 0.6× 30 2.9k

Countries citing papers authored by Guixi Zheng

Since Specialization
Citations

This map shows the geographic impact of Guixi Zheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guixi Zheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guixi Zheng more than expected).

Fields of papers citing papers by Guixi Zheng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guixi Zheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guixi Zheng. The network helps show where Guixi Zheng may publish in the future.

Co-authorship network of co-authors of Guixi Zheng

This figure shows the co-authorship network connecting the top 25 collaborators of Guixi Zheng. A scholar is included among the top collaborators of Guixi Zheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guixi Zheng. Guixi Zheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Zeyu, Hongxi Zhao, Pengyu Wang, et al.. (2025). A Novel Prognostic Signature Integrating Immune and Glycolytic Pathways for Enhanced Prognosis and Immunotherapy Prediction in Hepatocellular Carcinoma. Journal of Hepatocellular Carcinoma. Volume 12. 805–823.
2.
3.
Qu, Shuxin, et al.. (2025). Non‐Invasive Precise Classification of Glomerular Diseases in Urine Based on Hyperspectral Technology. Journal of Biophotonics. 19(1). e202500208–e202500208.
4.
Zhang, Xiaoyu, Xiaohan Li, Peng Su, et al.. (2024). Naringenin nanoparticles targeting cyclin B1 suppress the progression of rheumatoid arthritis-associated lung cancer by inhibiting fibroblast-to-myofibroblast transition. The International Journal of Biochemistry & Cell Biology. 169. 106557–106557. 2 indexed citations
5.
Bouamar, Hakim, Guixi Zheng, Junhua Yang, et al.. (2024). STEAP2 promotes hepatocellular carcinoma progression via increased copper levels and stress-activated MAP kinase activity. Scientific Reports. 14(1). 12753–12753. 4 indexed citations
6.
Zhang, Xiaoyu, Guixi Zheng, Xin Zhang, et al.. (2024). Hidden liver-joint axis: HBV infection causes rheumatoid arthritis via TRAFD1 with imbalance of HBV X protein and trans-ferulic acid. Virulence. 15(1). 2422540–2422540. 2 indexed citations
7.
Zhang, Zeyu, et al.. (2024). Unveiling ficolins: diagnostic and prognostic biomarkers linked to the Tumor Microenvironment in Lung Cancer. World Journal of Surgical Oncology. 22(1). 273–273. 1 indexed citations
8.
Zheng, Guixi, Lian‐Qiu Wu, Hakim Bouamar, et al.. (2024). Ficolin-3 induces apoptosis and suppresses malignant property of hepatocellular carcinoma cells via the complement pathway. Life Sciences. 357. 123103–123103. 2 indexed citations
9.
Liu, Shichao, et al.. (2024). Identification of necroptosis-associated miRNA signature for predicting prognosis and immune landscape in stomach adenocarcinoma. Experimental Cell Research. 436(1). 113948–113948. 1 indexed citations
10.
11.
Ye, Ping, Yanlian Yang, Liqiang Zhang, & Guixi Zheng. (2021). Prognostic Signatures of Alternative Splicing Events in Esophageal Carcinoma Based on TCGA Splice-Seq Data. Frontiers in Oncology. 11. 658262–658262. 1 indexed citations
12.
Chen, Guang, Hakim Bouamar, Bingzhi Wang, et al.. (2019). Everolimus Inhibits the Progression of Ductal Carcinoma In Situ to Invasive Breast Cancer Via Downregulation of MMP9 Expression. Clinical Cancer Research. 26(6). 1486–1496. 19 indexed citations
13.
Jiang, Xiumei, Lutao Du, Weili Duan, et al.. (2016). Serum microRNA expression signatures as novel noninvasive biomarkers for prediction and prognosis of muscle-invasive bladder cancer. Oncotarget. 7(24). 36733–36742. 48 indexed citations
14.
Zhang, Min, Ran Wei, Xiaomin Yang, et al.. (2015). Down-expression of miR-152 lead to impaired anti-tumor effect of NK via upregulation of HLA-G. Tumor Biology. 37(3). 3749–3756. 31 indexed citations
15.
Zhang, Xin, Xiaoyun Yang, Yanli Zhang, et al.. (2014). Direct Serum Assay for Cell-Free Bmi-1 mRNA and Its Potential Diagnostic and Prognostic Value for Colorectal Cancer. Clinical Cancer Research. 21(5). 1225–1233. 28 indexed citations
16.
Wang, Haiyan, Xin Zhang, Lili Wang, et al.. (2013). Investigation of cell free BIRC5 mRNA as a serum diagnostic and prognostic biomarker for colorectal cancer. Journal of Surgical Oncology. 109(6). 574–579. 30 indexed citations
17.
Zhang, Xuhua, Zhiying Xiao, Xiaoyong Liu, et al.. (2012). The Potential Role of ORM2 in the Development of Colorectal Cancer. PLoS ONE. 7(2). e31868–e31868. 39 indexed citations
18.
Wang, Shun, Lili Wang, Xin Zhang, et al.. (2011). Effects of subcutaneous low molecular weight heparin and intravenous unfractionated heparin on serum S100 concentrations in patients with cerebrovascular diseases. Clinical Chemistry and Laboratory Medicine (CCLM). 50(3). 525–8. 3 indexed citations
19.
Zhang, Xin, Chuanxin Wang, Lili Wang, et al.. (2011). Detection of circulating Bmi‐1 mRNA in plasma and its potential diagnostic and prognostic value for uterine cervical cancer. International Journal of Cancer. 131(1). 165–172. 28 indexed citations
20.
Deng, Xiaomei, Wei Li, Xiao Zhang, et al.. (2010). RNA Interference of Human Papillomavirus Type 16 E7 Increases HLA Class I Antigen Expression in HaCaT-E7 Cells. International Journal of Gynecological Cancer. 21(1). 28–34. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chang–Gong Liu Breakdown of academic impact, for papers by Qiong Shao Breakdown of academic impact, for papers by Xianjuan Shen Breakdown of academic impact, for papers by Natalia Ramírez Breakdown of academic impact, for papers by Fulin Qiang Breakdown of academic impact, for papers by Jianbin Xiang Breakdown of academic impact, for papers by Yong Song Breakdown of academic impact, for papers by Guoen Fang Breakdown of academic impact, for papers by Piet J. Pretorius Breakdown of academic impact, for papers by Nadia Felli
Rankless by CCL
2026